Management of intestinal involvement in systemic sclerosis.
Wollheim
Frank A
FA
Akesson
Anita
A
D004294:Domperidone / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D018589:Gastroparesis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D015282:Octreotide / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000150:complications* / Q000503:physiopathology
D018492:Dopamine Antagonists; D005765:Gastrointestinal Agents; D007211:Indoles; C105050:tegaserod; D004294:Domperidone; D008787:Metoclopramide; D015282:Octreotide